These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 13424488)

  • 41. [A CASE OF TOXIC NODULAR GOITER. OCCURRENCE OF FOCI OF PROLIFERATION OF LYMPHATIC TISSUE IN THE THYROID LOBES].
    LORDY C; BASTOSCDE O
    Bol Sanat Sao Lucas; 1964 Jan; 24():99-102. PubMed ID: 14184324
    [No Abstract]   [Full Text] [Related]  

  • 42. [A CASE OF TOXIC NODULAR GOITER. OCCURRENCE OF FOCI OF PROLIFERATION OF LYMPHATIC TISSUE IN THE THYROID LOBES].
    LORDY C; BASTOSCDE O
    An Paul Med Cir; 1964 Jan; 87():99-102. PubMed ID: 14183068
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunological study of a Hashimoto's goiter following mumps thyroiditis].
    EYQUEM A; CALMETTES C; DECOURT J
    Rev Fr Etud Clin Biol; 1959 Oct; 4():823-4. PubMed ID: 13821133
    [No Abstract]   [Full Text] [Related]  

  • 44. More on smoking habits and Graves' ophthalmopathy.
    Bartalena L; Martino E; Marcocci C; Bogazzi F; Panicucci M; Velluzzi F; Loviselli A; Pinchera A
    J Endocrinol Invest; 1989 Nov; 12(10):733-7. PubMed ID: 2614012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial risks for hospitalized Graves' disease and goiter.
    Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J
    Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A NEW CLINICAL FORM OF HYPERTHYROIDISM: EXOPHTHALMIC HYPERTHYROIDIZED GOITER].
    MILCU SM; NEGOESCU I; BALAN M; STANCU H
    Stud Cercet Endocrinol; 1964; 15():533-9. PubMed ID: 14338529
    [No Abstract]   [Full Text] [Related]  

  • 47. [Current views on the etiopathogenesis of goiter in children].
    Brzozowska M; Kretowski A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):35-43. PubMed ID: 16704860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [What is the role of allergic sensitization in Graves' disease?].
    Molnár I
    Orv Hetil; 2007 Jul; 148(29):1347-52. PubMed ID: 17631469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunological studies on Hashimoto's goiter consecutive to mumps thyroiditis].
    EYQUEM A; CALMETTES C; DECOURT J
    Rev Fr Etud Clin Biol; 1959 Oct; 4():823-4. PubMed ID: 13821132
    [No Abstract]   [Full Text] [Related]  

  • 50. [The role of auto-immune reactions in the pathogenesis of Hashimoto's goiter].
    MAHAUX J
    Rev Fr Etud Clin Biol; 1959 Nov; 4():885-7. PubMed ID: 14419933
    [No Abstract]   [Full Text] [Related]  

  • 51. HASHIMOTO'S STRUMA AND CARCINOMA OF THE THYROID.
    FLYNN JM
    J Kans Med Soc; 1964 Dec; 65():598-600. PubMed ID: 14227472
    [No Abstract]   [Full Text] [Related]  

  • 52. [A singular clinical variety of Graves' disease; Obese basedow in young women with primitive hypo-ovarism; Ethiopathogenesis and therapy considerations].
    BASSI M
    Riv Crit Clin Med; 1945 Oct; 45(3-5):209-43. PubMed ID: 20291671
    [No Abstract]   [Full Text] [Related]  

  • 53. DIAGNOSTIC PATTERNS. LESIONS OF THE THYROID GLAND.
    GOULD SE; HINERMAN DL; BATSAKIS JG; BEAMER PR
    Am J Clin Pathol; 1964 Jan; 41():87-90. PubMed ID: 14100681
    [No Abstract]   [Full Text] [Related]  

  • 54. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hyperthyroidism and carcinoma of the thyroid gland].
    Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
    Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Goiter and thyroid pathology in Belgium; therapeutic effects of thyroidine].
    BRULL L
    Rev Med Liege; 1950 Jan; 6(1):1-6. PubMed ID: 14816867
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of diffusion weighted MR imaging for differentiation between Graves' disease and Hashimoto thyroiditis.
    Ozturk T; Bozgeyik Z; Ozturk F; Burakgazi G; Akyol M; Coskun S; Ozkan Y; Ogur E
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2798-803. PubMed ID: 26241532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].
    Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J
    Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid autoimmunity and thyroid autonomy.
    Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
    Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
    Bohbot NL; Young J; Orgiazzi J; Buffet C; François M; Bernard-Chabert B; Lukas-Croisier C; Delemer B
    Eur J Endocrinol; 2006 Mar; 154(3):367-72. PubMed ID: 16498048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.